Inventor · disambiguated record
Glenn Michelson
Also filed as: MICHELSON GLENN · MICHELSON GLENN C
3 granted patents·8 pending applications·3 citations·filing 2006–2025
57Inventor score
Files withSUNESIS PHARMACEUTICALS INC5ALEXION PHARMA INC3ADELMAN DANIEL C1MICHELSON GLENN1MICHELSON GLENN C1
Top patents by PatentIndex Score
11 records- 0173US9724338B2Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·1 cites·6 claims
- 0269US11266645B2Methods for treating lymphomaALEXION PHARMA INC·Filed 2019·Granted Mar 8, 2022·0 cites·15 claims
- 0366US2011008371A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0466US2022233533A1Methods for treating lymphomaALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 0565US8299081B2Methods for treating drug resistant cancerMICHELSON GLENN C·Filed 2006·Granted Oct 30, 2012·2 cites·20 claims
- 0663US2025213562A1Methods for treating lymphomaALEXION PHARMA INC·Filed 2025·Application pending·0 cites
- 0754US2015190380A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0853US2008063642A1Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersADELMAN DANIEL C·Filed 2007·Application pending·0 cites
- 0950US2013102559A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disordersMICHELSON GLENN·Filed 2012·Application pending·0 cites
- 1049US2017368041A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1146US2017119745A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Glenn Michelson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →